REQUEST A DEMO
Total
USD $0.00
Search more companies

Biocells Discoveries Internacional S.A. (Ecuador)

Main Activities: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Full name: Biocells Discoveries Internacional S.A. Profile Updated: April 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Biocells specializes in processing and storing umbilical cord stem cells approved by the FDA. The company offers self-transplantation coverage for diseases treated with these stem cells, along with transportation kits. Biocells has a logistics team for cord blood unit transport and conducts annual stability monitoring. They are registered with the FDA for sample transportation and collect statistical information on customer interactions.

Headquarters
Portugal, Alicante Bldg.
Quito; Pichincha;

Contact Details: Purchase the Biocells Discoveries Internacional S.A. report to view the information.

Website: http://www.biocells.med.ec

Basic Information
Total Employees:
Purchase the Biocells Discoveries Internacional S.A. report to view the information.
Outstanding Shares:
Purchase the Biocells Discoveries Internacional S.A. report to view the information.
Registered Capital:
Purchase the Biocells Discoveries Internacional S.A. report to view the information.
Incorporation Date:
May 25, 2005
Key Executives
Purchase this report to view the information.
General Manager
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
57%
Purchase this report to view the information.
43%
Company Performance
Financial values in the chart are available after Biocells Discoveries Internacional S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
15.65%
Total operating revenue
14.92%
Operating profit (EBIT)
-58.69%
EBITDA
-54.17%
Net Profit (Loss) for the Period
32.48%
Total assets
13.56%
Total equity
68.16%
Operating Profit Margin (ROS)
-38.71%
Net Profit Margin
0.72%
Return on Equity (ROE)
-11.42%
Debt to Equity Ratio
19.7%
Quick Ratio
-0.23%
Cash Ratio
-0.05%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?